Literature DB >> 6452412

Detection of circulating immune complexes in the sera of rabbits with experimental syphilis: possible role in immunoregulation.

R E Baughn, K S Tung, D M Musher.   

Abstract

The in vivo and in vitro immunoglobulin G plaque-forming cell responses to sheep erythrocytes (SRBC) are nearly obliterated during disseminated syphilitic infection (3 to 8 weeks post-intravenous injection) in rabbits. Splenic and lymph node cells obtained from infected rabbits during this time period were capable of suppressing the normal in vitro responses of uninfected, SRBC-primed cells. Cell-free washings of cells from infected animals were also suppressive. This finding coupled with the fact that treatment of infected cells with proteolytic enzymes abrogated the suppressive effect constitute arguments against involvement of a specific suppressor cell population. The incidence of elevated levels of circulating immune complexes in the sera of rabbits with disseminated disease was also significantly different from that of uninfected controls or infected rabbits before the onset or after the regression of lesions. When added to cultures of lymphocytes from uninfected, SRBC-sensitized rabbits, sera containing complexes caused dose-related suppression of the in vitro immunoglobulin responses. Unlike immune complexes, no correlation was found between the presence of mucopolysaccharide materials and the stage of infection or the ability of serum to suppress the immunoglobulin responses to SRBC.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6452412      PMCID: PMC551159          DOI: 10.1128/iai.29.2.575-582.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

3.  Mechanism of immunologic tolerance. I. Induction of tolerance to bovine gamma-globulin by injection of antigen into intact organs in vitro.

Authors:  D W Scott; B H Waksman
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

4.  Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis.

Authors:  G M Levene; J L Turk; D J Wright; A G Grimble
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

5.  The microassay of hyaluronic acid concentration and hyaluronidase activity by capillary turbidity (CT) and capillary turbidity reduction (CTR) tests.

Authors:  A N Ibrahim; M M Streitfeld
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

6.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

7.  Lymphocyte transformation in syphilis: an in vitro correlate of immune suppression in vivo?

Authors:  D M Musher; R F Schell; R H Jones; A M Jones
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

8.  In vitro lymphocyte response to Treponema refringens im human syphilis.

Authors:  D M Musher; R F Schell; J M Knox
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

9.  Depression of lymphocyte response to concanavalin A in rabbits infected with Treponema pallidum (Nichols strain).

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  14 in total

1.  Contribution of rabbit leukocyte defensins to the host response in experimental syphilis.

Authors:  L A Borenstein; T Ganz; S Sell; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Immune studies in infants with congenital syphilis.

Authors:  G R Samson; D W Beatty; A F Malan
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Isolation and preliminary characterization of circulating immune complexes from rabbits with experimental syphilis.

Authors:  R E Baughn; D M Musher
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

4.  Serum regulation of in vitro lymphocyte responses in early experimental syphilis.

Authors:  S A Baker-Zander; S Sell; S A Lukehart
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

Review 5.  The Th1/Th2-like switch in syphilitic infection: is it detrimental?

Authors:  T J Fitzgerald
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

6.  Humoral response in Treponema pallidum-infected guinea pigs: I. Antibody specificity.

Authors:  K Wicher; A Jakubowski; V Wicher
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii.

Authors:  T J Fitzgerald
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Secondary lesions in rabbits experimentally infected with Treponema pallidum.

Authors:  R A Strugnell; L Drummond; S Faine
Journal:  Genitourin Med       Date:  1986-02

9.  Lymphocyte function in experimental endemic syphilis of Syrian hamsters.

Authors:  O Bagasra; H Kushner; S Hashemi
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

10.  Cyclophosphamide-sensitive activity of suppressor T cells during treponemal infection.

Authors:  D R Tabor; D P Kiel; R F Jacobs
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.